Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 7/2014

01.07.2014 | Original Article

Tumor Size Predicts Vascular Invasion and Histologic Grade Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma

verfasst von: Gaya Spolverato, Aslam Ejaz, Yuhree Kim, Georgios C. Sotiropoulos, Andreas Pau, Sorin Alexandrescu, Hugo Marques, Carlo Pulitano, Eduardo Barroso, Bryan M. Clary, Luca Aldrighetti, Todd W. Bauer, Dustin M. Walters, Ryan Groeschl, T. Clark Gamblin, Wallis Marsh, Kevin T. Nguyen, Ryan Turley, Irinel Popescu, Catherine Hubert, Stephanie Meyer, Jean-Francois Gigot, Gilles Mentha, Timothy M. Pawlik

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

The association between tumor size and survival in patients with intrahepatic cholangiocarcinoma (ICC) undergoing surgical resection is controversial. We sought to define the incidence of major and microscopic vascular invasion relative to ICC tumor size, and identify predictors of microscopic vascular invasion in patients with ICC ≥5 cm. A total of 443 patients undergoing surgical resection for ICC between 1973 and 2011 at one of 11 participating institutions were identified. Clinical and pathologic data were evaluated using uni- and multivariate analyses. As tumor sized increased, the incidence of microscopic vascular invasion increased: <3 cm, 3.6 %; 3–5 cm, 24.7 %; 5–7 cm, 38.3 %; 7–15 cm, 32.9 %, ≥15 cm, 55.6 %; (p < 0.001). Increasing tumor size was also found to be associated with worsening tumor grade. The incidence of poorly differentiated tumors increased with increasing ICC tumor size: <3 cm, 9.7 %; 3–5 cm, 19.8 %; 5–7 cm, 24.2 %; 7–15 cm, 21.1 %; >15 cm, 31.6 % (p = 0.04). The presence of perineural invasion (odds ratio [OR] = 2.98) and regional lymph node metastasis (OR = 4.43) were independently associated with an increased risk of microscopic vascular invasion in tumors ≥5 cm (both p < 0.05). Risk of microscopic vascular invasion and worse tumor grade increased with tumor size. Large tumors likely harbor worse pathologic features; this information should be considered when determining therapy and prognosis of patients with large ICC.
Literatur
1.
Zurück zum Zitat El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP: Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009, 49(1):116–123.PubMedCentralPubMedCrossRef El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP: Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology 2009, 49(1):116–123.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L et al.: Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of Surgery 2008, 248(1):84–96.PubMedCrossRef Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L et al.: Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of Surgery 2008, 248(1):84–96.PubMedCrossRef
3.
4.
Zurück zum Zitat Shaib YH, Davila JA, McGlynn K, El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? Journal of Hepatology 2004, 40(3):472–477.PubMedCrossRef Shaib YH, Davila JA, McGlynn K, El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? Journal of Hepatology 2004, 40(3):472–477.PubMedCrossRef
5.
Zurück zum Zitat Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. Journal of the National Cancer Institute 2006, 98(12):873–875.PubMedCrossRef Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. Journal of the National Cancer Institute 2006, 98(12):873–875.PubMedCrossRef
6.
Zurück zum Zitat Khan SA, Toledano MB, Taylor-Robinson SD: Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008, 10(2):77–82.CrossRef Khan SA, Toledano MB, Taylor-Robinson SD: Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008, 10(2):77–82.CrossRef
7.
Zurück zum Zitat de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L et al. 2011: Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of Clinical Oncology 29(23):3140–3145.PubMedCrossRef de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L et al. 2011: Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of Clinical Oncology 29(23):3140–3145.PubMedCrossRef
8.
Zurück zum Zitat Greene FL PD, Flemming ID, Friitz A, Balch CM, Heller DG, et al.: AJCC cancer staging manual. 6th ed.; 2002. Greene FL PD, Flemming ID, Friitz A, Balch CM, Heller DG, et al.: AJCC cancer staging manual. 6th ed.; 2002.
9.
Zurück zum Zitat Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM: a proposed staging system for intrahepatic cholangiocarcinoma. Annals of Surgical Oncology 2009, 16(1):14–22.PubMedCrossRef Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM: a proposed staging system for intrahepatic cholangiocarcinoma. Annals of Surgical Oncology 2009, 16(1):14–22.PubMedCrossRef
10.
Zurück zum Zitat Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M: A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001, 92(9):2374–2383.PubMedCrossRef Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M: A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001, 92(9):2374–2383.PubMedCrossRef
11.
Zurück zum Zitat Yamasaki S: Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. Journal of Hepato-Biliary-Pancreatic Surgery 2003, 10(4):288–291.PubMedCrossRef Yamasaki S: Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. Journal of Hepato-Biliary-Pancreatic Surgery 2003, 10(4):288–291.PubMedCrossRef
12.
Zurück zum Zitat Edge SBD, Compton C, Fritz A, Greene F, Trotti A: AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2010. Edge SBD, Compton C, Fritz A, Greene F, Trotti A: AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2010.
13.
Zurück zum Zitat Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E et al.: A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an eastern and western experience. JAMA surgery 2014. Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E et al.: A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an eastern and western experience. JAMA surgery 2014.
14.
Zurück zum Zitat Brennan MF, Kattan MW, Klimstra D, Conlon K: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Annals of Surgery 2004, 240(2):293–298.PubMedCentralPubMedCrossRef Brennan MF, Kattan MW, Klimstra D, Conlon K: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Annals of Surgery 2004, 240(2):293–298.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT et al.: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplantation 2005, 11(9):1086–1092.PubMedCrossRef Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT et al.: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplantation 2005, 11(9):1086–1092.PubMedCrossRef
16.
Zurück zum Zitat Compton CC, American Joint Committee on Cancer.: AJCC cancer staging atlas: a companion to the seventh editions of the AJCC cancer staging manual and handbook, 2nd edn. Compton CC, American Joint Committee on Cancer.: AJCC cancer staging atlas: a companion to the seventh editions of the AJCC cancer staging manual and handbook, 2nd edn.
17.
Zurück zum Zitat Liu ZH, Chen Z, Ma LL, Li XH, Wang LX: Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma. Acta Gastro-enterologica Belgica 2012, 75(2):215–218.PubMed Liu ZH, Chen Z, Ma LL, Li XH, Wang LX: Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma. Acta Gastro-enterologica Belgica 2012, 75(2):215–218.PubMed
18.
Zurück zum Zitat Saxena A, Chua TC, Sarkar A, Chu F, Morris DL: Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. Journal of Gastrointestinal Surgery 2010, 14(7):1128–1138.PubMedCrossRef Saxena A, Chua TC, Sarkar A, Chu F, Morris DL: Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. Journal of Gastrointestinal Surgery 2010, 14(7):1128–1138.PubMedCrossRef
19.
Zurück zum Zitat Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y: Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Annals of Surgical Oncology 2010, 17(7):1816–1822.PubMedCrossRef Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y: Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Annals of Surgical Oncology 2010, 17(7):1816–1822.PubMedCrossRef
20.
Zurück zum Zitat Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33(6):1394–1403.PubMedCrossRef Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33(6):1394–1403.PubMedCrossRef
21.
Zurück zum Zitat Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM: Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer 2013, 119(22):3929–3942.PubMedCrossRef Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM: Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer 2013, 119(22):3929–3942.PubMedCrossRef
Metadaten
Titel
Tumor Size Predicts Vascular Invasion and Histologic Grade Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma
verfasst von
Gaya Spolverato
Aslam Ejaz
Yuhree Kim
Georgios C. Sotiropoulos
Andreas Pau
Sorin Alexandrescu
Hugo Marques
Carlo Pulitano
Eduardo Barroso
Bryan M. Clary
Luca Aldrighetti
Todd W. Bauer
Dustin M. Walters
Ryan Groeschl
T. Clark Gamblin
Wallis Marsh
Kevin T. Nguyen
Ryan Turley
Irinel Popescu
Catherine Hubert
Stephanie Meyer
Jean-Francois Gigot
Gilles Mentha
Timothy M. Pawlik
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 7/2014
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-014-2533-1

Weitere Artikel der Ausgabe 7/2014

Journal of Gastrointestinal Surgery 7/2014 Zur Ausgabe

SSAT/ASCRS Joint Symposium

Revision IPAA: Strategies for Success

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.